Use of serum B‐cell maturation antigen levels to predict outcomes for myeloma patients treated with ruxolitinib, lenalidomide and methylprednisolone-Reference-Cited by-同舟云学术

Use of serum B‐cell maturation antigen levels to predict outcomes for myeloma patients treated with ruxolitinib, lenalidomide and methylprednisolone

Published:2022-01-15 Issue:2 Volume:40 Page:243-248
ISSN:0278-0232
Container-title:Hematological Oncology
language:en
Short-container-title:Hematological Oncology

Author:

Bujarski Sean¹,Sutanto Christine²,Spektor Tanya M.³,To Jennifer³,Swift Regina A.¹,Green Tracy¹,Eades Benjamin R.¹,Emamy‐Sadr Marsiye¹,Souther Eric²,Berenson James R.¹²³⁴^ORCID

Affiliation:

1. James R. Berenson, MD, Inc. West Hollywood California USA

2. OncoTracker West Hollywood California USA

3. Oncotherapeutics West Hollywood California USA

4. Institute for Myeloma and Bone Cancer Research West Hollywood California USA

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hon.2961

Reference19 articles.

1. Molecular aspects of multiple myeloma

2. Serum B-cell maturation antigen: a novel biomarker to predict outcomes for multiple myeloma patients

3. Multiple myeloma: 2018 update on diagnosis, risk-stratification, and management

4. New generation drugs for treatment of multiple myeloma

5. Comparison of three different serum-free light-chain assays—implications on diagnostic and therapeutic monitoring of multiple myeloma

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elevated serum levels of soluble B-cell maturation antigen as a prognostic biomarker for multiple myeloma;Clinical and Experimental Immunology;2024-05-14

2. Biomarkers of Efficacy and Safety of the Academic BCMA-CART ARI0002h for the Treatment of Refractory Multiple Myeloma;Clinical Cancer Research;2024-03-11

3. Soluble B‐cell maturation antigen in multiple myeloma;American Journal of Hematology;2024-01-25

4. Clinical Outcomes and Serum B-Cell Maturation Antigen Levels in a Real-World Unselected Population of Newly Diagnosed Multiple Myeloma Patients;Targeted Oncology;2023-09

5. The role of soluble B cell maturation antigen as a biomarker in multiple myeloma;Leukemia & Lymphoma;2022-10-25